CSL - Stock

CSL Equity 2024

CSL Equity

15.79 B USD

Ticker

CSL.AX

ISIN

AU000000CSL8

WKN

890952

In 2024, CSL's equity was 15.79 B USD, a 8.29% increase from the 14.58 B USD equity in the previous year.

CSL Aktienanalyse

What does CSL do?

CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing CSL's Equity

CSL's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding CSL's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating CSL's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

CSL's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in CSL’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about CSL Stock

What is the equity of CSL this year?

CSL has equity of 15.79 B USD this year.

What was the equity of CSL compared to the previous year?

The equity of CSL has increased/decreased by 8.29% increased compared to the previous year.

What impact does a high equity have on investors of CSL?

A high equity is advantageous for investors of CSL as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of CSL?

A low equity can be a risk for investors of CSL, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of CSL affect the company?

An increase in equity of CSL can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of CSL affect the company?

A reduction in equity of CSL can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of CSL?

Some factors that can affect the equity of CSL include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of CSL so important for investors?

The equity of CSL is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can CSL take to change the equity?

To change equity, CSL can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does CSL pay?

Over the past 12 months, CSL paid a dividend of 3.72 USD . This corresponds to a dividend yield of about 1.91 %. For the coming 12 months, CSL is expected to pay a dividend of 3.92 USD.

What is the dividend yield of CSL?

The current dividend yield of CSL is 1.91 %.

When does CSL pay dividends?

CSL pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of CSL?

CSL paid dividends every year for the past 27 years.

What is the dividend of CSL?

For the upcoming 12 months, dividends amounting to 3.92 USD are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is CSL located?

CSL is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSL from 4/3/2024 amounting to 1.799 USD, you needed to have the stock in your portfolio before the ex-date on 3/11/2024.

When did CSL pay the last dividend?

The last dividend was paid out on 4/3/2024.

What was the dividend of CSL in the year 2023?

In the year 2023, CSL distributed 3.257 USD as dividends.

In which currency does CSL pay out the dividend?

The dividends of CSL are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The CSL stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von CSL

Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.